Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (171-180 of 476) with videos related to

Pageof 48
Sort By:
Nature Reviews. Drug Discovery|March 31, 2012
AfliberceptMichael W Stewart, Seden Grippon, Peter Kirkpatrick
Nature Reviews. Drug Discovery|July 6, 2006
RanolazineJonathan Abrams, Carole A Jones, Peter Kirkpatrick
Nature Reviews. Drug Discovery|January 28, 2009
AlvimopanConor P Delaney, Uma Yasothan, Peter Kirkpatrick
Expert Opinion on Investigational Drugs|November 1, 2011
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsAndreas Varkaris, Paul G Corn, Sanchaika Gaur, et al.
Cancer Research|January 28, 2004
Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancerAmado J Zurita, Patricia Troncoso, Marina Cardó-Vila, et al.
Statistics in Medicine|April 12, 2007
Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoringPeter F Thall, Leiko H Wooten, Christopher J Logothetis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone MicroenvironmentIoulia Vardaki, Paul Corn, Emanuela Gentile, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2021
Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostateWan-Fu Wu, Li Wang, Nicholas Spetsieris, et al.
European Urology|February 21, 2015
Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate CancerCelestia S Higano, Tomasz M Beer, Mary-Ellen Taplin, et al.
Nature Reviews. Drug Discovery|September 28, 2006
DasatinibHagop Kantarjian, Elias Jabbour, Joanne Grimley, et al.
Pageof 48

Showing results (171-180 of 476) with videos related to

Sort By:
Pageof 48
Nature Reviews. Drug Discovery|March 31, 2012
AfliberceptMichael W Stewart, Seden Grippon, Peter Kirkpatrick
Nature Reviews. Drug Discovery|July 6, 2006
RanolazineJonathan Abrams, Carole A Jones, Peter Kirkpatrick
Nature Reviews. Drug Discovery|January 28, 2009
AlvimopanConor P Delaney, Uma Yasothan, Peter Kirkpatrick
Expert Opinion on Investigational Drugs|November 1, 2011
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsAndreas Varkaris, Paul G Corn, Sanchaika Gaur, et al.
Cancer Research|January 28, 2004
Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancerAmado J Zurita, Patricia Troncoso, Marina Cardó-Vila, et al.
Statistics in Medicine|April 12, 2007
Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoringPeter F Thall, Leiko H Wooten, Christopher J Logothetis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone MicroenvironmentIoulia Vardaki, Paul Corn, Emanuela Gentile, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2021
Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostateWan-Fu Wu, Li Wang, Nicholas Spetsieris, et al.
European Urology|February 21, 2015
Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate CancerCelestia S Higano, Tomasz M Beer, Mary-Ellen Taplin, et al.
Nature Reviews. Drug Discovery|September 28, 2006
DasatinibHagop Kantarjian, Elias Jabbour, Joanne Grimley, et al.
Pageof 48